Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cougar Biotechnology (CGRB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CGRB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on CGRB
Biotech: Q3 Market Update
[View article]
Thank you for the market numbers, well researched. Keep posting.
Comment by
cyrussmith123
Dec 18 01:23 am
|
Rating:
0
0
Cougar Biotechnology: Stalking Prostate Cancer
[View article]
A doctor told my partner that prostate stimulation can help as a preventative action towards prostate cancer. What are your thoughts on...
More »
Comment by
Prostate Stimulation
Oct 7 15:20 pm
|
Rating:
0
0
Healthcare companies still desperate for a partner
[View instapost]
NeurogesX: Astellas Deal a Major Positive by: Zacks.com June 22, 2009 | about: ALPMF.PK / NGSX By Jason...
More »
Comment by
Janine McCargo
Jun 30 15:25 pm
|
Rating:
0
0
Healthcare companies still desperate for a partner
[View instapost]
You think Dendreon is desperate? I think you are Clueless! Dendreon WHEN they announce their Partner it will be a Shell SHOCK as to the...
More »
Comment by
USisCorrupt
Jun 30 13:50 pm
|
Rating:
+1
-1
Healthcare companies still desperate for a partner
[View instapost]
You think Dendreon is desperate? I think you are Clueless! Dendreon WHEN they announce their Partner it will be a Shell SHOCK as to the...
More »
Comment by
USisCorrupt
Jun 30 13:50 pm
|
Rating:
+1
-1
Healthcare companies still desperate for a partner
[View instapost]
I think you made a mistake in your cut and paste. Poniard's Picoplatin and Arena's Lorcaserin are in phase 3.
Comment by
Jolly_Rancher
Jun 30 13:33 pm
|
Rating:
0
0
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
As we have been highlighting since ASCO, prostate cancer remains in vogue with investors. Medarex (MEDX) now surging today on Mayo...
More »
Comment by
Michael Becker
Jun 22 11:10 am
|
Rating:
0
0
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
In reviewing all 29 of your comments throughout SeekingAlpha, I noticed that all of them promote ACCP. However, my article referencing...
More »
Comment by
Michael Becker
Jun 20 10:02 am
|
Rating:
0
0
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
Greg - I read some of your various comments and it appears that you also know a thing or two about the industry. Beyond focusing on the...
More »
Comment by
Michael Becker
Jun 20 09:49 am
|
Rating:
0
0
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
Thanks for your article. It's refreshing to read articles related to the biotech/pharma sector from someone knowledgeable in how drug...
More »
Comment by
Greg Parker
Jun 20 09:40 am
|
Rating:
+2
0
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
GNBT has a prostrate cancer vaccine that was recently in the news with positive test results as well. Trying to find more and...
More »
Comment by
guitarz
Jun 19 23:07 pm
|
Rating:
0
-1
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
[View article]
you mention PARD, another company working on a new and improved platinum drug is ACCP:...
More »
Comment by
svygear
Jun 19 15:50 pm
|
Rating:
0
-1
Biotech Stocks and the ASCO-Effect
[View article]
Post-ASCO, new 52-week high today - OncoGenex Pharmaceuticals, Inc. (OGXI)
Comment by
Michael Becker
Jun 4 12:08 pm
|
Rating:
0
0
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
[View article]
MARK CIFRA-Since you are so informative to many investors, and helpful, I see you left out one stock that needs to be addressed...
More »
Comment by
jimmy Turano
Jun 3 18:59 pm
|
Rating:
+1
0
Access Pharma: A Smallcap Cancer Biotech Call Option Trade
[View article]
Mike Oh well he must have checked out for now.....
Comment by
fwallace55
Jun 2 06:22 am
|
Rating:
0
0
1
2
3
4
Next Page
Biotech: Q3 Market Update [View article]
Cougar Biotechnology: Stalking Prostate Cancer [View article]
Healthcare companies still desperate for a partner [View instapost]
Healthcare companies still desperate for a partner [View instapost]
Healthcare companies still desperate for a partner [View instapost]
Healthcare companies still desperate for a partner [View instapost]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer [View article]
Biotech Stocks and the ASCO-Effect [View article]
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly [View article]
Access Pharma: A Smallcap Cancer Biotech Call Option Trade [View article]